Filing Details
- Accession Number:
- 0001415889-24-023520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-17 16:30:09
- Reporting Period:
- 2024-09-16
- Accepted Time:
- 2024-09-17 16:30:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636178 | James Edgemond | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Cfo And Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-16 | 3,267 | $120.26 | 7,007 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-16 | 3,267 | $339.12 | 3,740 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-16 | 3,400 | $117.76 | 7,140 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-16 | 3,400 | $339.12 | 3,740 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-16 | 817 | $120.26 | 4,557 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-16 | 562 | $339.12 | 3,995 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-16 | 850 | $117.76 | 4,845 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-16 | 581 | $339.12 | 4,264 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-09-16 | 3,267 | $0.00 | 3,267 | $120.26 |
| Common Stock | Stock Options | Disposition | 2024-09-16 | 3,400 | $0.00 | 3,400 | $117.76 |
| Common Stock | Stock Options | Disposition | 2024-09-16 | 817 | $0.00 | 817 | $120.26 |
| Common Stock | Stock Options | Disposition | 2024-09-16 | 850 | $0.00 | 850 | $117.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,405 | 2017-03-15 | 2026-03-15 | No | 4 | M | Direct |
| 142,100 | 2021-03-15 | 2027-03-15 | No | 4 | M | Direct |
| 28,588 | 2017-03-15 | 2026-03-15 | No | 4 | M | Direct |
| 141,250 | 2021-03-15 | 2027-03-15 | No | 4 | M | Direct |
Footnotes
- This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 17, 2024.
- This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 817 stock options, sold 562 of the resulting shares of common stock, and held the remaining 255 shares of common stock.
- This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 850 stock options, sold 581 of the resulting shares of common stock, and held the remaining 269 shares of common stock.
Billionaire Hedge Funds
